Credit: Getty Images. The final guidance clarifies that drugs developed for inhalational anthrax prophylaxis can rely on evidence from animal studies (the Animal Rule) to support approval when the ...

Inhalational anthrax caused by Bacillus anthracis is associated with high mortality primarily due to toxin-mediated injury. Raxibacumab is a human IgG1λ monoclonal antibody directed against protective ...

SILVER SPRING, Maryland — A US Food and Drug Administration (FDA) advisory panel has endorsed the use of a novel treatment for inhalational anthrax. At a hearing on November 2, the FDA's ...

The FDA has approved Anthim (obiltoxaximab; Elusys) injection for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial agents, and for the ...

The Minnesota Department of Health (MDH) is working with the Centers for Disease Control and Prevention (CDC) to investigate an apparent case of inhalational anthrax in an individual who officials ...

Scientists have demonstrated that postexposure vaccination can shorten the duration of antibiotic treatment required to protect against inhalational anthrax. The findings, which appear in this week's ...

The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus ...

The theory about how the country’s anthrax attack unfolded last month seemed pretty plausible. Yes, the story had loose ends, but the basic idea was that anyone who’d come down with the disease had ...

The US Food and Drug Administration (FDA) has approved anthrax immune globulin intravenous (Anthrasil, Emergent BioSolutions) for treatment of inhalational anthrax in combination with appropriate ...

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to ...